Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica

British Journal of Haematology
J LeslieY B Gordon

Abstract

Coagulation studies were carried out in 117 Jamaicans with homozygous sickle-cell disease in the steady state, and 40 local controls. The patients had significantly higher factor-VIII levels, higher platelet counts, lower factor-V and plasminogen levels, shorter thrombin times and higher serum fibrinogen degradation products (FDP) than the control group. The low factor-V and plasminogen levels, and high FDP levels, might be explained by activation of the coagulation system and continuous clot lysis even in the absence of painful crisis. The high factor-VIII levels and short thrombin times found in these patients could not be explained.

References

Jan 4, 1969·British Medical Journal·A Mahmood
Sep 1, 1972·British Journal of Haematology·M C Brain
Apr 1, 1969·British Journal of Haematology·J Niemetz, H L Nossel
Dec 1, 1969·British Journal of Haematology·G R SerjeantP F Milner
Apr 1, 1967·British Journal of Haematology·G Burn
Oct 23, 1969·The New England Journal of Medicine·H A PearsonE A Cornelius
Jan 1, 1967·British Journal of Haematology·C F AbildgaardI Schulman
Sep 9, 1967·British Medical Journal·A MahmoodA G Shaper
Dec 1, 1950·Journal of Applied Physiology·G BRECHER, E P CRONKITE

❮ Previous
Next ❯

Citations

Dec 25, 2003·The American Journal of Medicine·Kenneth I Ataga, Eugene P Orringer
May 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·C M MooreR U Sorensen
Jun 1, 1978·British Journal of Haematology·E M Essien, O Ayeni
Jan 1, 1979·British Journal of Haematology·S G RichardsonR M Wilcox
Oct 1, 1976·Journal of Clinical Pathology·S G RichardsonJ Stuart
Jul 1, 1980·Journal of Clinical Pathology·M W KennyJ Stuart
Dec 1, 1987·Journal of Clinical Pathology·A A Famodu
Jan 15, 1993·Experientia·A D Adekile, T H Huisman
Oct 30, 2007·Free Radical Biology & Medicine·Mutay Aslan, Bruce A Freeman
Apr 19, 2013·British Journal of Haematology·Erica Sparkenbaugh, Rafal Pawlinski
May 17, 2011·British Journal of Haematology·Edwige Balayssac-SiransyPascal Bogui
Aug 1, 1981·British Journal of Haematology·M J Stuart, R H Sills
Sep 1, 1994·Baillière's Clinical Haematology·L A Harker, S R Hanson
Dec 1, 1996·Hematology/oncology Clinics of North America·S K Ballas, N Mohandas
Nov 12, 2016·Blood Cells, Molecules & Diseases·Emmanuelle CharrinCyril Martin
Jan 1, 1997·Journal of Child Neurology·D A Tam
Dec 12, 2001·Pediatrics International : Official Journal of the Japan Pediatric Society·A K Bayazit, Y Kilinç
Jan 11, 2018·Lung India : Official Organ of Indian Chest Society·Abhinav AgrawalArunabh Talwar
Jan 1, 1978·Stroke; a Journal of Cerebral Circulation·K H MerkelM J Post
Nov 21, 2007·Hematology·Kenneth I Ataga, Nigel S Key
Dec 1, 1994·American Journal of Hematology·P A LaneR A Marlar
Aug 1, 1992·American Journal of Hematology·S I BerneyI B Kovacs
Jan 1, 1990·Clinical and Laboratory Haematology·A A FamoduH L Reid
Aug 1, 1989·American Journal of Hematology·C Beurling-Harbury, S G Schade
Dec 5, 1998·American Journal of Hematology·S A Zimmerman, R E Ware
Mar 17, 2007·Hemoglobin·Fiekumo I BuseriZaccheaus A Jeremiah
Aug 21, 2020·Haematologica·Arun S ShetRakhi P Naik
Oct 16, 2020·Haematologica·Arun S ShetRakhi P Naik
Jun 1, 2001·The Journal of Laboratory and Clinical Medicine·A TomerJ R Eckman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.